Presentation is loading. Please wait.

Presentation is loading. Please wait.

Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008]  Douglas.

Similar presentations


Presentation on theme: "Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008]  Douglas."— Presentation transcript:

1 Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008]  Douglas D. Taylor, Cicek Gercel-Taylor  Gynecologic Oncology  Volume 116, Issue 1, (January 2010) DOI: /j.ygyno Copyright © 2009 Elsevier Inc. Terms and Conditions

2 Fig. 2 Presence of small RNA associated with circulating EpCAM-positive exosomes from ovarian cancer patients. Panel A: representative analysis of the RNA isolated from tumor exosomes using Agilent 2100 Bioanalyzer. Panel B: agarose gel (1%) separation of total RNA from circulating exosomes and corresponding tumors. The low molecular weight RNA (LMW RNA) is indicated within the box. This total RNA was used as the starting material for microRNA profiling. Gynecologic Oncology  , DOI: ( /j.ygyno ) Copyright © 2009 Elsevier Inc. Terms and Conditions


Download ppt "Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008]  Douglas."

Similar presentations


Ads by Google